Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.

Autor: Richtig E; Department of Dermatology, Medical University of Graz, Graz., Nguyen VA; Department of Dermatology, Medical University of Innsbruck, Innsbruck., Koelblinger P; Department of Dermatology and Allergology, Paracelsus Private Medical University, Salzburg., Wolf I; Department of Dermatology, Medical University of Graz, Graz., Kehrer H; Department of Dermatology, Ordensklinikum Linz Elisabethinen, Linz., Saxinger W; Department of Dermatology, Klinikum Wels-Grieskirchen, Wels., Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna., Weinlich G; Department of Dermatology, Medical University of Innsbruck, Innsbruck., Meyersburg D; Department of Dermatology and Allergology, Paracelsus Private Medical University, Salzburg., Hafner C; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten., Jecel-Grill E; Department of Dermatology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St Pölten., Kofler J; Department of Dermatology, Klinikum Klagenfurt am Wörthersee, Klagenfurt., Lange-Asschenfeldt B; Department of Dermatology, Klinikum Klagenfurt am Wörthersee, Klagenfurt., Weihsengruber F; Department of Dermatology and Venereology, Rudolfstiftung Hospital, Vienna., Rappersberger K; Department of Dermatology and Venereology, Rudolfstiftung Hospital, Vienna., Svastics N; Dermatologische Ambulanz, Landesklinikum Wiener Neustadt, Wiener Neustadt., Gasser K; Department of Oncology and Hematology, LKH Feldkirch, Rankweil., Seeber A; Department of Dermatology, SMZ Ost, Vienna., Kratochvill F; Novartis Pharma GmbH, Vienna, Austria., Nagler S; Novartis Pharma GmbH, Vienna, Austria., Mraz B; Novartis Pharma GmbH, Vienna, Austria., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna.

Publikováno v: Melanoma research [Melanoma Res] 2024 Apr 01; Vol. 34 (2), pp. 142-151. Date of Electronic Publication: 2023 Dec 13.

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.

Autor: Brüggen MC; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France., Walsh S; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, King's College Hospital, London, England, United Kingdom., Ameri MM; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne-Center for Allergy Research and Education (CK-CARE), Davos, Switzerland., Anasiewicz N; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Maverakis E; Department of Dermatology, University of California, Davis, Sacramento, California., French LE; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.; Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida., Ingen-Housz-Oro S; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France.; Toxic Bullous Dermatoses TOXIBUL Reference Center, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France., Abe R; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Ardern-Jones M; Department of Dermatology, Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, England, United Kingdom., Assier H; Department of Dermatology, Henri Mondor University Hospital, University of Paris-Est Créteil, Créteil, France., Barbaud A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hospital, Department of Dermatology and Allergology, Paris, France., Bensaid B; Department of Dermatology, Lyon Natecia Hospital, Lyon, France., Bernal W; Liver Intensive Therapy Unit, King's Critical Care, King's College Hospital, London, England, United Kingdom., Bernier C; Department of Dermatology, University Hospital Nantes, Nantes, France., Brassard A; Department of Dermatology, University of California, Davis, Sacramento, California., Brezinová E; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatovenereology, St Anne's Faculty Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Cabañas R; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain.; PIELenRed Consortium, Madrid, Spain.; Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain., Cardones A; Department of Dermatology, University of Kansas, Kansas City., Chu CY; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Chua SL; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology, University of California, San Francisco., Descamps V; Department of Dermatology, Bichat-Claude Bernard Hospital, Paris Diderot University, Paris, France., Didona B; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Center of Rare Diseases IDI-IRCCS, Rome, Italy., Divito SJ; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Dodiuk-Gad R; Department of Dermatology, Emek Medical Center, Afula, Israel.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Elman S; Department of Dermatology, Miller School of Medicine, University of Miami, Miami, Florida., Gaspar K; Department of Dermatology, University of Debrecen, Debrecen, Hungary., Mortz CG; Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Hama N; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Lee HY; Department of Dermatology, Singapore General Hospital, Singapore, Singapore., Horváth B; Center for Blistering Diseases, Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Jörg L; Division of Allergology and Clinical Immunology, Department of Pneumology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Kaffenberger BH; Department of Dermatology, The Ohio State University, Columbus, Ohio., Kucinskiene V; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences (LUHS), Hospital of LUHS Kauno Klinikos, Kaunas, Lithuania., Lebrun-Vignes B; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France., Lehloenya RJ; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Meyersburg D; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University, Salzburg, Austria., Micheletti R; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Images in Dermatology Editor, JAMA Dermatology., Milpied B; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Center, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Miyagawa F; Department of Dermatology, Nara Medical University, Kashihara, Japan., Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Nägeli M; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Naldi L; Department of Dermatology, Ospedale San Bortolo, Vicenza, Italy., Oppel E; Department of Dermatology and Allergy, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany., Phillips EJ; Department of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee., Pirani T; Liver Intensive Therapy Unit, King's Critical Care, King's College Hospital, London, England, United Kingdom., Ranki A; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Mälkönen T; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Rosenbach M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Salavastru C; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Paediatric Dermatology, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Staumont-Salle D; CHU Lille, Department of Dermatology, Univ Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE) F-59000, Lille, France., Sandberg H; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Setterfield J; Department of Oral Medicine, Guy's and St Thomas' NHS Foundation Trust, London, England, United Kingdom., Shinkai K; Department of Dermatology, University of California, San Francisco.; Editor, JAMA Dermatology., Shiohara T; Department of Dermatology, Kyorin University School of Medicine, Mitaka, Japan., Soria A; Department of Dermatology and Allergology, Tenon Hospital, Sorbonne Universite, Paris, France., Tartar D; Department of Dermatology, University of California, Davis, Sacramento, California., Tiplica GS; ToxiTEN group, European Reference Network for Rare Skin Diseases (ERN-Skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Traidl S; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Vorobyev A; Department of Dermatology, University Hospital Lübeck, Lübeck, Germany., von Wachter C; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Worswick S; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles., Cho YT; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Publikováno v: JAMA dermatology [JAMA Dermatol] 2024 Jan 01; Vol. 160 (1), pp. 37-44.

Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases.

Autor: Kridin K; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel., Brüggen MC; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Medical Campus Davos, Davos, Switzerland.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin)., Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology, King's College Hospital, London, UK., Bensaid B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.; Department of Dermatology, Edouard Herriot Hospital, Lyon, France., Ranki A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Inflammation Center, Helsinki, Finland., Oppel E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany., Meyersburg D; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria., Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Seeli C; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland., Sandberg H; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Inflammation Center, Helsinki, Finland., French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany.; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA., Vorobyev A; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Department of Dermatology, University Medical Center Schleswig-Holstein, Lübeck, Germany., Ingen-Housz-Oro S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-Skin).; Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.; Department of Dermatology, AP-HP, Henri Mondor Hospital, Créteil, France.; Univ Paris Est Créteil EpiDermE, Créteil, France.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 Apr; Vol. 37 (4), pp. 753-762. Date of Electronic Publication: 2022 Dec 19.

Erratum: Contact sensitization to plants of the Compositae family: Data of the Information Network of Departments of Dermatology (IVDK) from 2007 to 2016 (vol 80, pg 222, 2019)

Autor: Baron, J. M., Grabbe, J., Ludwig, A., Bircher, A., Laubstein, B., Zuberbier, T., Worm, M., Simon, D., Effendy, Isaak, Dickel, H., Fartasch, M., Meyersburg, D., Patsinakidis, N., Zutt, M., Große-Hüttmann, P., Hausenblas, P., Martin, V., Reich, K., Breuer, K., Vieluf, D., Jung, A., Lippert, U., Pilz, B., Frosch, P. J., Mydlach, B., Pirker, C., Herbst, R., Kügler, K., Beiteke, U., Richter, G., Aschoff, R., Spornraft-Ragaller, P., Bauer, A., Koch, A., Peters, K. -P., Diepgen, T. L., Hertl, M., Mahler, V., Wagner, N., Ockenfels, H. -M., Hillen, U., Schwantes, H., Szliska, Ch., Geier, J., Meyer, J., Grunwald-Delitz, H., Kaatz, M., Kränke, B., Aberer, W., Jünger, M., Fuchs, Th., Buhl, T., Gaber, G., Lübbe, D., Kreft, B., Kiehn, M., Wessbecher, R., Coors, E., Witte, J., Seemann, U., Schröder-Kraft, C., Schaefer, T., Werfel, Th., Kapp, A., Schulze-Dirks, A., Hartmann, M., Jappe, U., Schäkel, K., Weisshaar, E., Löffler, H., Bahmer, F. A., Koch, P., Pföhler, C., Gebhardt, M., Wigger-Alberti, W., Schliemann, S., Brasch, J., Spring, P., Curdin, C., Treudler, R., Nestoris, St., Shimanovich, I., Hartmann, K., Recke, A., Becker, D., Bayerl, Ch., Kurzen, H., Booken, D., Klemke, C. -D., Ludwig-Peitsch, W., Schmieder, A., Pfützner, W., Hoffmann, J., Stadler, R., Oppel, T., Przybilla, B., Thomas, P., Schuh, T., Eben, R., Molin, S., Agathos, M., Ramrath, K., Georgi, M., Isbary, G., Rakoski, J., Darsow, U., Biedermann, T., Hellweg, B., Brehler, R., Behring, M., Müller, I., Debus, D., Bachtler, A., Ertner, K., Baur, V., Padeken, M., Kautz, O., Uter, W., John, S. M., Schwanitz, H. J., Schürer, N., Skudlik, Ch., Prager, W., Heise, H., Trcka, J., Rothaupt, D., Plaza, T., Nist, G., Rieker-Schwienbacher, J., Lischka, G., Roecken, M., Fischer, J., Staib, G., Hinrichs, R., Weiss, J., Arnold, J., Trautmann, A., Knopf, B., Teubner, D., Mechtel, D., Ballmer-Weber, B., Navarini, A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2294::e47daf59d1d8dfdc5c3c3bc3b4512b99
https://pub.uni-bielefeld.de/record/2968771

Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children.

Autor: Riebenbauer K; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Weber PB; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Haitel A; Department of Pathology, Medical University of Vienna, Vienna, Austria., Walochnik J; Molecular Parasitology, Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria., Valencak J; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Meyersburg D; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria., Kinaciyan T; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Handisurya A; Department of Dermatology, Medical University of Vienna, Vienna, Austria. Electronic address: alessandra.handisurya@meduniwien.ac.at.

Publikováno v: The Journal of pediatrics [J Pediatr] 2022 Jun; Vol. 245, pp. 184-189. Date of Electronic Publication: 2022 Feb 14.